Issue: January 2019
January 01, 2019
1 min read
Save

T-TIME

Issue: January 2019
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Evaluation of the safety and efficacy of low doses of intra-coronary alteplase (Activase, Genentech) in patients undergoing PCI.